Abstract: Cyclic redundancy check-aided tail-biting convolutional code (CRC-TBCC) is considered as a competitive candidate for ultra-reliable and low-latency communications (URLLC) in short-length ...
Abstract: In non-cooperative communications, receivers lack prior channel coding knowledge, making error correction code recognition critical. Recursive systematic ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results